What is the latest status of the project “Lilly Huntsville API Manufacturing Facility”?

The status recorded for “Lilly Huntsville API Manufacturing Facility” is planned.

What is the budget and commercial profile for the project “Lilly Huntsville API Manufacturing Facility”?

Taiyo normalizes the budget of “Lilly Huntsville API Manufacturing Facility” to USD 6000000000.

Where can I verify the source and access all details for “Lilly Huntsville API Manufacturing Facility”?

This Taiyo project page references Fierce Pharma along with the original URL (https://www.fiercepharma.com/pharma/roll-tide-lilly-selects-alabama-site-location-6b-api-facility-0). Taiyo standardizes official data into a consistent, searchable project profile.

Lilly Huntsville API Manufacturing Facility

Sector: Manufacturing (Industrial) • Location: Huntsville, Alabama, United States

Source: Fierce Pharma

Project

Planned

Eli Lilly has selected Huntsville, Alabama, as the site for a $6 billion plant to produce active pharmaceutical ingredients (APIs) for peptide and small-molecule medicines, including the GLP-1 weight-loss pill, orforglipron. The facility is part of Lilly's plan to build four large-scale manufacturing facilities in the U.S. Construction is expected to start in 2026 and complete in 2032, generating

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Huntsville, Alabama, United States of America
Updated: 22 Jul 2026
Source: Fierce Pharma

ConstructChat

Ask ConstructChat about Lilly Huntsville API Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “Lilly Huntsville API Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Huntsville, Alabama, United States. Taiyo aggregates data on it from Fierce Pharma.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Eli Lilly has selected Huntsville, Alabama, as the site for a $6 billion plant to produce active pharmaceutical ingredients (APIs) for peptide and small-molecule medicines, including the GLP-1 weight-loss pill, orforglipron. The facility is part of Lilly's plan to build four large-scale manufacturing facilities in the U.S. Construction is expected to start in 2026 and complete in 2032, generating 3,000 construction jobs and employing 450 personnel at the complex.
Original sector	Pharmaceutical Manufacturing
Budget

Location

Country	United States of America (USA)
State	Alabama
City	Huntsville

Source

Source	Fierce Pharma
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-12-12

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Lilly Huntsville API Manufacturing Facility

Ask ConstructChat about Lilly Huntsville API Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States